Caveat mTOR: Aberrant signaling disrupts corticogenesis

Journal of Clinical Investigation

Volumn 120, Issue 5, 2010, Pages 1392-1395

  Osborne, Lucy R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; RAPAMYCIN; STE20 RELATED KINASE ADAPTOR ALPHA; STE20 RELATED KINASE ADAPTOR BETA; UNCLASSIFIED DRUG;

ALEXANDER DISEASE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN NERVE CELL; CELL GROWTH; CELL MIGRATION; CELL POLARITY; COWDEN SYNDROME; EPILEPSY; HAMARTOMA; HUMAN; HYDRAMNIOS; LEARNING DISORDER; NONHUMAN; NOTE; POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY SYNDROME; PRION DISEASE; PRIORITY JOURNAL;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BRAIN; CELL MOVEMENT; EPILEPSY; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEARNING DISORDERS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEURONS; PHENOTYPE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 77951816885     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI43030     Document Type: Note

References (18)

1. Leventer RJ, Guerrini R, Dobyns WB. Malformations of cortical development and epilepsy. Dialogues Clin Neurosci. 2008;10(1):47-62.
2. Puffenberger EG, et al. Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5. Brain. 2007;130(Pt 7):1929-1941.
3. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet. 2005;37(1):19-24. (Pubitemid 40070934)
4. Orlova KA, et al. STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest. 2010; 120(5):1591-1602.
5. Dowling RJ, Topisirovic I, Fonseca BD, Sonenberg N. Dissecting the role of mTOR: Lessons from mTOR inhibitors. Biochim Biophys Acta. 2010;1804(3):433-439.
6. Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M. The mTOR pathway and its role in human genetic diseases. Mutat Res. 2008;659(3):284-292.
7. Boudeau J, et al. MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J. 2003;22(19):5102-5114. (Pubitemid 37222030)
8. Barnes AP, et al. LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons. Cell. 2007;129(3):549-563.
9. Asada N, Sanada K, Fukada Y. LKB1 regulates neuronal migration and neuronal differentiation in the developing neocortex through centrosomal positioning. J Neurosci. 2007;27(43):11769-11775. (Pubitemid 350006887)
10. Kim JS, Hung W, Narbonne P, Roy R, Zhen M. C. elegans STRADalpha and SAD cooperatively regulate neuronal polarity and synaptic organization. Development. 2010;137(1):93-102.
11. Franz DN, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006;59(3):490-498.
12. Koenig MK, Northrup H. Topical rapamycin therapy to alleviate cutaneous manifestations of tuberous sclerosis complex (TSC) and neurofibromatosis I (NF1). http://www.clinicaltrials.gov/ct2/show/NCT01031901.
13. Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, D'Arcangelo G. Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia. Dis Model Mech. 2009;2(7-8):389-398.
14. Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol. 2008; 63(4):444-453. (Pubitemid 351614710)
15. Ehninger D, et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med. 2008;14(8):843-848.
16. Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci. 2005;8(12):1727-1734.
17. Zeng LH, Rensing NR, Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci. 2009;29(21):6964-6972.
18. Buckmaster PS, Ingram EA, Wen X. Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. J Neurosci. 2009;29(25):8259-8269.